LP37725-6
Coagulation factor VIII Ab
Active
Description
FVIII concentrated from donated blood plasma (Aafact), or alternatively recombinant FVIII can be given to hemophiliacs to restore hemostasis.
Antibody formation to Factor VIII can also be a major concern for patients receiving therapy against bleeding; the incidence of these inhibitors is dependent of various factors, including the Factor VIII product itself.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Wikipedia
Basic Part Properties
- Part Name
- Coagulation factor VIII Ab
- Part Display Name
- Coagulation factor VIII Ab
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2006-05-09
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 凝血因子 VIII 抗体 Synonyms: 凝血因子 VIII Ab; |
| fr-FR | French (France) | Facteur VIII anticorps |
| pl-PL | Polish (Poland) | Czynnik krzepnięcia VIII Ab Synonyms: Przeciwciało do czynnika VIII krzepnięcia |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://